Health AGTC to Present Three-Month Interim Results from the SKYLINE Clinical Trial of AGTC-501 for the Treatment of X-Linked Retinitis Pigmentosa at the 45th Macula Society Annual Meeting June 6, 2022
Health HTG Technology Featured in Multiple Scientific Abstracts Highlighting Novel Applications in Precision Medicine at ASCO 2022 June 6, 2022
Health Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 2, 2022